Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

EVOlocumab for Early Reduction of LDL-cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) (EVOPACS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03287609
Recruitment Status : Completed
First Posted : September 19, 2017
Last Update Posted : August 14, 2019
Sponsor:
Collaborators:
Amgen
University of Bern
Information provided by (Responsible Party):
University Hospital Inselspital, Berne

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 20, 2019
Actual Study Completion Date : August 7, 2019
Publications of Results: